Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesBeta-Adrenergic Antagonists in Hypertension: A Review of the Evidence
Annals of Pharmacotherapy, 11/25/09
Warmack TS et al. – Overall, data supporting Beta–blockers as preferred therapy in hypertension are inadequate. Although most negative cardiovascular and cerebrovascular outcomes of beta–blockers were associated with atenolol therapy, data supporting other beta–blockers in hypertension are lacking.
Related Articles
Lessons in Hypertension from New Clinical Trials
Postgraduate Medicine, 11/24/09
Relevance Score: 94%
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Decrease in FASN Expression in Adipose Tissue of Hypertensive Individuals
American Journal of Hypertension, 11/23/09
Relevance Score: 92%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Beneficial Electrophysiological Effects of Trimetazidine in Patients With Postischemic Chronic Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, 02/09/10
Effects of landiolol on left ventricular function during electroconvulsive therapy: a transthoracic echocardiographic study
Journal of Anesthesia, 02/09/10
Efficacy and Safety of Ticagrelor: A Reversible P2Y12 Receptor Antagonist
Annals of Pharmacotherapy, 02/09/10
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Renal Sympathetic Denervation and Systemic Hypertension
The American Journal of Cardiology, 02/09/10
Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27
Hypertension Research, 02/08/10
Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study
Hypertension Research, 02/08/10
Article Search
Sponsor
Sponsor